www.skpcrossborder.com Jul 31, 2004
Your eye to India-centric and International updates
India Inc - Investment briefs

Pune continues to attract substantial inward investments

The $1.5bln construction equipment major, JCB plans to set up a Rs 600-crore manufacturing facility near Pune. The new plant is expected to cater to the UK-based company’s Southeast Asian market, comprising Myanmar, Thailand, Singapore, Malaysia and Korea, currently handled by the UK plant.

JCB is one of the world’s top-five construction equipment producers, with four manufacturing plants in US, Brazil, UK and Ballabgarh, near New Delhi in India. JCB’s entry into India started in 1979 with a JV with Escorts group which later turned into a 100% subsidiary in1990. With sales of over $ 123 mln, the Indian operations manufacture backhoe loaders, wheeler loaders, robot skid steers and tracked excavators, besides making customised earthmoving equipment for institutional sales to various government departments.

JCB's Pune expansion plans are part of the Company's well thought out strategy in the wake of competition from rival Terex Vectra’s entry into India.

Our Say

JCB is the second multinational to have set up in Pune’s upcoming industrial belt, in recent times. It was preceded by, Korean giant LG’s $ 111 mln manufacturing plant. This is a positive trend of relative preference being shown towards Pune being an ideal location not just for IT but also manufacturing.

Top

French Accor plans more Indian buys

The French hospitality giant Accor, plans to set up two separate companies in India. Taking the acquisition route for its India operations, one of the subsidiaries will look specifically at identifying, sourcing and acquiring property in project hotel sites and also construct project hotels. It will also serve to identify hotel owners and contract with them by way of sale, lease or license agreements.

The other subsidiary is expected to provide support services such as management, training consultation, sales and marketing services, etc to hotels in India, Sri Lanka, Nepal and Bangladesh.

Accor’s investments into the two proposed companies will be brought in through the Bangkok-based AAPC (Thailand), which is a subsidiary of Accor Asia Pacific, which in turn is a wholly-owned subsidiary of the French parent Accor.

NPIL to launch global dermo-cosmetic range

Nicholas Piramal India (NPIL) has entered into an alliance with French pharma major, Laboratories Pierre Fabre, to manufacture and market a range of dermatology and dermo-cosmetic products in India.

To begin with NPIL will launch two products from Pierre Fabre’s portfolio. The formulations will mark NPIL’s entry into the dermo-cosmetic segment. It will however eventually introduce to the Indian market the French Company’s entire range which includes remedies for anti-ageing, stretch marks, acne, premature hair loss, etc.

For Pierre Fabre, the alliance allows the company to explore the huge Indian market. This would also be the Labs first overseas market where there would be value–add to the final stages of manufacturing, since the products will be formulated in India at NPIL’s Pithampur facility though the intermediates will be imported from France.

Print this ArticleTop
In the News
Gujarat plans SEZ for auto components
Rajasthan’s biotechnology policy to boost investment

Interesting Reads
Liaison offices could be taxable in India!
A tale of many cities!!
Interest paid to OCB in Mauritius taxable here
Worth a read

India Inc
- Investment briefs
Pune continues to attract substantial inward investments
French Accor plans more Indian buys
NPIL to launch global dermo-cosmetic range
IOB looks at Malaysia, China for foreign push
Baxter may make India outsourcing hub for API
Marriott to focus on India

Hope you enjoyed this edition of ‘eye to I’
Please feel free to mail us -
-
any suggestions / comments that would help us enhance this e-supplement
-
requests for further information or advice
-
a request to meet
© 2004 SKP Crossborder Consulting Pvt Ltd Email to a Friend | Unsubscribe | Feedback | Disclaimer